Clinical Trials for Alumis

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alumis

Clinical Trials (7)

NCT06962774
An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function
PHASE1Recruiting
48 participants
Started: May 9, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT06952634
An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage
PHASE1Recruiting
48 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT06846541
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
PHASE3Recruiting
1,680 participants
Started: Jan 8, 2025 · Completed: Nov 30, 2028
5 conditions1 sponsor263 locations
NCT06588738
A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001
PHASE3Active, not recruiting
840 participants
Started: Aug 20, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor148 locations
NCT06586112
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis
PHASE3Active, not recruiting
840 participants
Started: Jul 25, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor183 locations
NCT05966480
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
PHASE2Active, not recruiting
408 participants
Started: Jun 26, 2023 · Completed: Sep 1, 2027
1 condition1 sponsor169 locations
NCT05739435
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
PHASE2Active, not recruiting
165 participants
Started: Jan 17, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor38 locations